Howard Zelin Strives To Provide Innovative Capital Solutions to Meet the Challenges of Real Estate Marketplace
Howard Zelin is a dedicated and highly-experienced professional providing innovative capital solutions to efficiently meet the challenges of a rapidly evolving commercial real estate marketplace. He has acquired extensive experience in the field of real estate financing for various projects involving construction. He has completed his B.S. from Syracuse University and J.D. from Toura Law School.
Howard Zelin’s professional experience includes the following:
He is serving as the President of the Zell Development Corp. Here, he provides acquisition, development and construction of various projects along the east coast. The company handles several multi-family projects in Brooklyn and the Bronx; and many single family construction projects in New York, Florida and Massachusetts.
Prior to this, he served as the President of New Atlantic Capital Corp. that provides Commercial Bridge Loans and Hard Money Loans. The company has numerable partnerships with institutional private investment firms that allow them to provide the capital clients need at any time. They originate, manage and service alternative investment products, which include first mortgage bridge loans and construction loans, mezzanine debt, preferred equity and non-performing loan strategies.
Before this, Howard also served as the President of the Dorchester Building Corp. where he managed the Construction of single family and Multi –family residential housing in the tri- state area.
Howard Zelin donates to Pediatric MS for providing comprehensive evaluation and care to children and teens up to the age of 18 with MS and related central nervous system (CNS) and demyelinating disorders. Today, the network has evolved to include several centers that are engaged in research for the better understanding of the cause of MS, it’s characteristics in children, and most importantly, how best to treat children with MS. These centers offer evaluation, diagnosis, treatment and support to families with a child displaying symptoms related to this disease and; a child does not need to have a definite diagnosis of MS in order to be evaluated.